版本:
中国

BRIEF-Cytokinetics announces first patient enrolled in VIGOR-ALS

Oct 18 Cytokinetics Inc :

* Cytokinetics announces first patient enrolled in VIGOR-ALS, an open-label extension clinical trial of tirasemtiv Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐